Instil Bio, Inc.TILEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Curative Ventures V LLC | 29.20% | 1.9M | — | 2024-10-22 |
| Vivo Capital IX, LLC | 9.00% | 585.5K | — | 2024-11-14 |
| Perceptive Advisors LLC | 5.30% | 345.5K | — | 2024-09-27 |
| Venrock Healthcare Capital Partners II, L.P. | 0.50% | 33.2K | — | 2024-11-14 |
| Boxer Capital, LLC | 0.00% | 45.8K | ▼ -5.50pp | 2024-10-25 |
| BML Investment Partners, L.P. | — | 346.2K | — | 2024-04-02 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.